Did you know?
- Between 5 and 10% of all hospital admissions are medicines-related
- Two thirds of medicines-related hospital admissions are preventable
- The overall NHS drugs bill is £16.8 billion a year
- The NHS drugs bill is rising by 8% a year which is more than the current annual increase in funding
- A 2010 report estimated the national figure for pharmaceutical waste to be £300 million
Medicines Value Programme aims
The Medicines Value Programme has been set up to improve health outcomes from medicines and ensure we are getting the best value from the NHS medicines bill. It aims to:
- Enable people to access treatment that is clinically effective, based on the latest scientific discovery, at as low a price as possible
- Support people to take their medicines as intended, with appropriate medicines reviews, so that they get the health outcomes they want.
There are four workstreams:
1. Policy framework
The policy framework that governs access to and pricing of medicines within the NHS, working with the Department of Health and Social Care and National Institute for Health and Care Excellence (NICE).
2. Commercial arrangements
The commercial arrangements that influence price, including the work of NHS England’s Commercial Medicines Unit, and Commercial Team.
3. Optimising the use of medicines
Optimising the use of medicines includes:
- Developing and supporting the work of the four Regional Medicines Optimisation Committees to drive the changes that are needed in prescribing and medicines use.
- Improving health outcomes from medicines through improving patient information, making best use of the clinical skills of pharmacists and pharmacy technicians, and implementing clinically effective prescribing and medicines reviews.
- Supporting the anti-microbial resistance campaign – which focuses on reducing the overuse of antibiotics.
- Increasing the use of best value biological and generic medicines, including biosimilar medicines where appropriate.
- Decreasing or stopping the use of medicines which are neither clinically- or cost-effective.
- Implementing the quality and innovation goals – known as a ‘CQUIN’ – for medicines optimisation within specialised services.
4. Developing the infrastructure
The programme covers the entire NHS system of secondary and primary care and involves a wide range of organisations including NHS Improvement and Health Education England.